Kidney
The goal of this group is to develop cellular and molecular based regenerative medicine therapies that can treat patients in the early stages of kidney disease and help to prevent them from developing life threatening end stage kidney disease.
Liver
The long term goal of this group is to develop more sensitive and specific methods to detect changes in chronic and acute liver disease earlier and to develop cellular and molecular-based regenerative medicine therapies (RMTs). This enables doctors to treat patients in the early stages of liver disease and prevent them from developing irreversible liver failure.
Eye
The aim of this group is to develop and support regenerative and reconstructive therapies from the basic science in our laboratories to patients within the clinics in St Paul’s Eye Unit, to tackle the debilitating diseases that underlie vision loss and blindness.
Gut
Researchers study two gut areas: the intestinal epithelium, seeking therapies to speed repair after IBD damage, and the enteric nervous system, developing treatments for Hirschsprung's disease.
Musculoskeletal
The aim of this group is to better understand the molecular mechanisms causing tissue degeneration in the musculoskeletal system and to use stem cells and tissue engineering to reconstruct damaged tissue, alleviate pain and improve the quality of life of patients and elderly people.